Last reviewed · How we verify
carbocisteine cough syrup
At a glance
| Generic name | carbocisteine cough syrup |
|---|---|
| Also known as | Mucolit, Lisomucil |
| Sponsor | Clalit Health Services |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Comparison of Efficacy and Tolerability of Two Cough Syrups in Cough Due to Cold in Children. (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- carbocisteine cough syrup CI brief — competitive landscape report
- carbocisteine cough syrup updates RSS · CI watch RSS
- Clalit Health Services portfolio CI